 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Strategic Marketing & Business Development
Cedara Software Corp.
905.672.2100 x 2564 jacques.cornet@cedara.com |
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
Attention: Business/Financial Editors:
CEDARA SOFTWARE TO DEBUT NEW SOLUTIONS FOR INTEGRATED IMAGING
WORKFLOW AT THE 2006 RSNA CONFERENCE
- Cedara to demonstrate its new C4 integration platform, a system that allows
OEM companies to tightly integrate clinical applications into their existing
solutions
- Through a single integration effort, C4 allows companies to support diverse
functionality for their customers including breast imaging, PET/CT, orthopaedic
planning, virtual colonoscopy, calcium scoring, oncology therapy response,
lung nodule analysis and more
- Solutions contribute to Cedara’s range of products and services for rapid
application development in the healthcare space
Toronto, ON, November 15, 2006 – Cedara Software, a Merge Healthcare company (Nasdaq:
MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, today announced plans to introduce new solutions for integrated imaging workflow at the 2006 RSNA conference held November 26 – 30 in Chicago, Illinois.
With the increasing prevalence of multiple PACS installations, clinical applications and information systems used at a single healthcare institution, the need for integration has never been greater. At RSNA 2006, Cedara Software will showcase a variety of new technologies for OEM/VARs designed to further unite image and information management in the healthcare industry. In this rapidly changing landscape, Cedara’s solutions provide a fast, efficient and cost effective means to introduce new technology to the marketplace.
At the forefront of Cedara’s approach to integrated image and information management is a new development platform, named C4 (Cedara Clinical Control Center™*). C4 is an innovative platform that allows clinical applications and plug-ins to be tightly integrated into a single workstation, sharing system resources. Operating through a single patient study list, each clinical application can be launched manually or automatically based on user preferences. While C4 can be used to quickly integrate clinical applications into any information system, it will be demonstrated at RSNA with Cedara’s web enabled PACS system Cedara I-Reach™, a diagnostic information system Cedara aXigate™, and in a standalone capacity.
Clinical needs addressed via C4 currently include breast imaging, PET/CT imaging, orthopaedic planning, virtual colonoscopy, calcium scoring, oncology therapy response and lung nodule analysis.These capabilities are supported by Cedara’s clinical applications Cedara IReadMammo™, Cedara PET/CT Workstation, Cedara OrthoWorks ProPlanner™*, Cedara OrthoWorks Spine Analyzer™, Cedara IlumiView™, Cedara CalScore®, Cedara I-Response™*, Cedara PrimeLung™ and more. It is anticipated that additional clinical applications will be available through C4 in the future.
"C4 promises to set a new standard for integration and ease-of-use for clinical applications in the healthcare industry,” said Ken Rardin, President of Cedara Software and CEO of Merge Healthcare. “For many vendors, engineering costs and time-to-market have a significant impact on their decision to develop applications that address specialists’ needs; using C4, these applications can be quickly added to existing PACS, RIS and EMR solutions to support a more a comprehensive workflow in a fast and cost effective manner."
To support rapid application development, Cedara will also demonstrate a variety of solutions that have been built using the Cedara OpenEyes development platform. Cedara OpenEyes sets a new industry standard for rapid application development. Including all of the essential imaging functionality for high-level viewing solutions such as volume rendering in 3D, OpenEyes’ programming model represents a paradigm shift from previous technologies, completely insulating clients from the complexities of deep code development by providing a single uniform set of controls and development interfaces. OpenEyes packages connectivity, visualization and printing services in a flexible and transparent architecture that can be deployed across a wide spectrum of application environments-- from small "one-off" projects to complex web solution services. Cedara OpenEyes is available to OEM organizations interested in accelerating their time to market.
Cedara’s offerings at RSNA will include a wide range of solutions for including image enhancement for modality manufacturers, segmentation solutions, deformable registration, tumour contouring, connectivity products, image stitching, CAD, RIS/PACS, automatic measurements, 3D, tools for integrated diagnostic information and more.
"Today’s need for service capabilities that stretch across the entire healthcare enterprise, put significant pressure on companies that have traditionally played in niche markets," continued Rardin. "Cedara is in a very unique position to help medical technology companies broaden their market reach and accelerate their time-to-market. From our development platforms and toolkits to complete applications that can be private labeled and seamlessly operate within\ another host, Cedara has a large range of products for the OEM community. Cedara’s long history and experience with custom engineering services also provide a cost effective means to ramp up product development and provide additional support for internal resources. Any company interested in seeing Cedara’s next generation solutions should visit our booth at RSNA."
Cedara Software will be located at booth 4716, Hall A (South Hall) at McCormick Place in Chicago, Illinois during the annual meeting of the Radiology Society of North America (RSNA) held November 26 - 30, 2006.
*Some of the capabilities mentioned above represent works-in-progress.
# # #
Cedara Software is a Merge Healthcare company focused on the development of custom
engineered software applications and development tools for the medical imaging OEM and
International markets. Cedara software is deployed in hospitals and clinics worldwide and is
licensed by many of the world's leading medical device and healthcare information technology
companies. Cedara technologies and expertise span all the major digital imaging modalities
including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and
information management software and services. With over twenty years of leadership in the
medical imaging and healthcare information technology markets, Merge Healthcare provides
innovative solutions for both OEM and the end-user healthcare markets. We custom engineer
clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
